Pharmaceutical Companies Are Doing Much More Than Battling COVID-19
The merger of Pfizer's Upjohn business with Mylan NV (NASDAQ: MYL), along with the potential of its COVID-19 vaccine candidate that it's developing with BioNTech, makes Pfizer a potential winner during COVID-19.